Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · IEX Real-Time Price · USD
120.28
-1.43 (-1.17%)
Apr 30, 2024, 4:00 PM EDT - Market closed
Zimmer Biomet Holdings Revenue
In the year 2023, Zimmer Biomet Holdings had annual revenue of $7.39B with 6.55% growth. Revenue in the quarter ending December 31, 2023 was $1.94B with 6.30% year-over-year growth.
Revenue (ttm)
$7.39B
Revenue Growth
+6.55%
P/S Ratio
3.40
Revenue / Employee
$410,789
Employees
18,000
Market Cap
25.11B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
Dec 31, 2019 | 7.98B | 49.30M | 0.62% |
Dec 31, 2018 | 7.93B | 129.60M | 1.66% |
Dec 31, 2017 | 7.80B | 134.90M | 1.76% |
Dec 31, 2016 | 7.67B | 1.67B | 27.85% |
Dec 31, 2015 | 6.00B | 1.32B | 28.34% |
Dec 31, 2014 | 4.67B | 49.90M | 1.08% |
Dec 31, 2013 | 4.62B | 151.70M | 3.39% |
Dec 31, 2012 | 4.47B | 19.90M | 0.45% |
Dec 31, 2011 | 4.45B | 231.60M | 5.49% |
Dec 31, 2010 | 4.22B | 124.80M | 3.05% |
Dec 31, 2009 | 4.10B | -25.70M | -0.62% |
Dec 31, 2008 | 4.12B | 223.60M | 5.74% |
Dec 31, 2007 | 3.90B | 402.10M | 11.50% |
Dec 31, 2006 | 3.50B | 209.30M | 6.37% |
Dec 31, 2005 | 3.29B | 305.20M | 10.24% |
Dec 31, 2004 | 2.98B | 1.08B | 56.81% |
Dec 31, 2003 | 1.90B | 528.60M | 38.52% |
Dec 31, 2002 | 1.37B | 193.80M | 16.44% |
Dec 31, 2001 | 1.18B | 138.00M | 13.26% |
Dec 31, 2000 | 1.04B | 101.70M | 10.83% |
Dec 31, 1999 | 938.90M | 77.90M | 9.05% |
Dec 31, 1998 | 861.00M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cardinal Health | 216.15B |
Baxter International | 14.81B |
Biogen | 9.66B |
ICON PLC | 8.23B |
STERIS | 5.41B |
BioNTech SE | 4.24B |
Align Technology | 3.86B |
Mettler-Toledo International | 3.79B |
ZBH News
- 26 days ago - Zimmer Biomet Becomes First and Only Official Medical Device Partner of Association of Pickleball Players, Professional Pickleball Association, and USA Pickleball - PRNewsWire
- 27 days ago - Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Zimmer Biomet Receives FDA Clearance for ROSA® Shoulder System - the World's First Robotic Assistant for Shoulder Replacement Surgery - PRNewsWire
- 2 months ago - Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2024 - PRNewsWire
- 2 months ago - Zimmer Biomet Signs Global Health Equity Network's Zero Health Gaps Pledge and Expands Longstanding Commitment to Advancing Health Equity - PRNewsWire
- 2 months ago - Zimmer Biomet Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting - PRNewsWire
- 2 months ago - Zimmer Biomet forecasts upbeat 2024 profit on steady medical devices demand - Reuters
- 2 months ago - Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial Results - PRNewsWire